Vertex Pharmaceuticals
VRTX
#201
Rank
HK$871.44 B
Marketcap
HK$3,434
Share price
-2.66%
Change (1 day)
4.45%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): HK$132.87

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$133.21. In 2025 the company made an earnings per share (EPS) of HK$121.15 an increase over its 2024 EPS that were of -HK$16.13.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$132.879.67%
2025HK$121.15-850.97%
2024-HK$16.13-114.67%
2023HK$109.958.17%
2022HK$101.6542.64%
2021HK$71.26-12.67%
2020HK$81.60128.01%
2019HK$35.79-44.54%
2018HK$64.53670.09%
2017HK$8.38-327.66%
2016-HK$3.68-79.65%
2015-HK$18.09-26.43%
2014-HK$24.5953.92%
2013-HK$15.98316.33%
2012-HK$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.42-48.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.10-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.64-59.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.86-79.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.88-79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-HK$29.99-122.52%๐Ÿ‡บ๐Ÿ‡ธ USA